Heart Failure and Volume Management
Clinical research at Centro Cardiologico Monzino S.p.A. includes chronic congestive heart failure, with attention to symptom burden, fluid balance, and functional capacity. The sponsor’s trials focus on treatment approaches used in congestive heart failure care and on preserving cardiopulmonary performance.
- Diuretic therapy
- Exercise capacity
- Alveolar-capillary diffusion
- Euvolemia
These studies reflect interest in optimizing medical management for patients with persistent heart failure symptoms and impaired fluid regulation.
Arrhythmogenic Cardiomyopathy and Right Ventricular Function
The sponsor also studies arrhythmogenic cardiomyopathy with a focus on right ventricular deterioration and disease progression. This area of research is directed toward understanding structural and functional changes in the right ventricle over time.
- Right ventricular deterioration
- Cardiomyopathy progression
- Cardiac structure
- Functional preservation
Work in this field centers on clinical strategies relevant to patients with inherited or acquired myocardial disease affecting ventricular performance.
Cardiovascular Pharmacotherapy
Research activity includes evaluation of established cardiovascular drugs used in heart disease management, with interest in how these agents may influence disease evolution and organ function. The sponsor’s studies involve medication classes commonly used in cardiology practice.
- Statins
- Atorvastatin
- Cholesterol-lowering therapy
- Cardiac protection
This area connects pharmacologic treatment with prevention of worsening cardiac impairment in selected patient groups.
